FDAFDA · Food and drugs·Recall number D-0042-2024
BREXAFEMME (Ibrexafungerp) tablets 150 mg, 4 count cartons, Rx Only, Manufactured for and distributed by SCYNEXIS, Inc., Jersey City, NJ 07302 NDC 75788-115-04
Published October 18, 2023 · Recall initiated: September 25, 2023
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products: Potential cross-contamination of ibrexafungerp citrate drug substance with ezetimibe (a non-antibacterial beta-lactam compound).
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Manufacturer
- Scynexis, Inc.
- Distributor
- Nationwide in the US.
- Lot
- Lot# LF21000008, Exp. 11/30/2023 Lot# LF22000051, Exp. 11/30/2025
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.